These cytokines could be promising rapid diagnostic testing candidates, particularly given the independent correlation of CXCL10 with CM development and mortality in both African and Indian cohorts in serum and CSF samples (Armah et al., 2007; Jain et al., 2008) (Table 1). This evidence concerns the gene CXCL10 and cutaneous mastocytosis.